Table. Infection-related signs and symptoms during MCPyV and TSPyV seroconversions compared with previous and subsequent intervals for asymptomatic polyomavirus infections in children, Finland, January 2011–July 2013*.
Virus sign/symptom | Interval, no. (%) |
|
Previous interval |
Subsequent interval |
|||
---|---|---|---|---|---|---|---|
No. (%) | p value | No. (%) | p value | ||||
MCPyV seroconversion, n = 45 | |||||||
URTI | 14 (31.8) | 10 (22.2) | 0.4545 | 18 (41.9) | 0.3018 | ||
LRTI | 3 (6.8) | 2 (4.4) | 1.0000 | 3 (7.0) | 1.0000 | ||
Fever without RTI | 2 (6.8) | 2 (4.4) | 1.0000 | 3 (7.0) | 0.6250 | ||
Gastroenteritis | 9 (20.5) | 9 (20.0) | 1.0000 | 11 (25.6) | 0.5488 | ||
Acute tonsillitis | 1 (2.3) | 0 | ND | 1 (2.3) | 1.0000 | ||
Acute otitis media | 10 (22.7) | 11 (24.4) | 1.0000 | 13 (30.2) | 0.6291 | ||
Acute conjunctivitis | 2 (4.5) | 1 (2.2) | 1.0000 | 1 (2.3) | 1.0000 | ||
Exanthema | 7 (15.9) | 1 (2.2) | 0.0703 | 1 (2.3) | 0.0703 | ||
Acute sinusitis | 2 (4.5) | 0 | ND | 1 (2.3) | 1.0000 | ||
Total | 32 (72.7) | 26 (57.8) | 0.2632 | 31 (72.1) | 1.0000 | ||
No data |
1 |
|
0 |
NA |
|
2 |
NA |
TSPyV seroconversion, n = 39 | |||||||
URTI | 14 (35.9) | 9 (23.1) | 0.3593 | 13 (35.1) | 1.0000 | ||
LRTI | 3 (7.7) | 3 (7.7) | 1.0000 | 2 (5.4) | 1.0000 | ||
Fever without RTI | 2 (5.1) | 5 (12.8) | 0.3750 | 4 (10.8) | 0.6875 | ||
Gastroenteritis | 10 (25.6) | 12 (30.8) | 0.7744 | 5 (13.5) | 0.3877 | ||
Acute tonsillitis | 1 (2.6) | 1 (2.6) | 1.0000 | 2 (5.4) | 1.0000 | ||
Acute otitis media | 8 (20.5) | 12 (30.8) | 0.3877 | 8 (21.6) | 1.0000 | ||
Acute conjunctivitis | 4 (10.3) | 5 (12.8) | 1.0000 | 3 (8.1) | 1.0000 | ||
Exanthema | 2 (5.1) | 3 (7.7) | 1.0000 | 1 (2.7) | 1.0000 | ||
Acute sinusitis | 3 (7.7) | 2 (5.1) | 1.0000 | 2 (5.4) | ND | ||
Total | 32 (82.1) | 30 (76.9) | 0.7266 | 30 (81.1) | 1.0000 | ||
No data |
0 |
|
0 |
NA |
|
2 |
NA |
*Liddell exact test was used; p<0.05 was considered significant. MCPyV, Merkel cell polyomavirus; TSPyV, trichodysplasia spinulosa-associated polyomavirus; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection; ND, no data; NA, not applicable. |